Dashboard
Analysis
Charting
Screener
Resources
Settings
NasdaqGS-MELI
Mar '15
Dec '16
Sep '18
Jun '20
Mar '22
Dec '23
Sep '25
Trailing Valuation
Stock Price
2,336.9
2,613.6
1,950.9
1,700.4
2,052
1,643.4
Total Shares Outstanding
50.7
Market Cap
118,476.3
132,504.2
98,904
86,207.8
104,029.1
83,316.2
Total Enterprise Value (TEV)
115,439.3
129,961.2
97,050
83,873.8
102,364.1
80,823.2
Buyback Yield
—
0%
Debt Paydown Yield
-2%
-2.5%
-2.3%
-1.3%
-1.1%
Shareholder Yield
P/S
4.5
5.5
4.4
4.1
5.4
4.7
P/Gross Profit
10
12
9.6
9
11.7
9.8
P/E
45.1
72.4
59.4
Earnings Yield
2.2%
1.4%
1.7%
P/OCF
12.1
15.6
13.3
10.9
15
P/FCF
13.8
17.9
15.3
12.2
17.8
16.1
FCF Yield
7.3%
5.6%
6.5%
8.2%
6.2%
P/B
19.1
23.2
19.8
26
22.8
EV/Sales
4.3
4
4.6
EV/Gross Profit
11.8
9.4
8.8
11.5
9.5
EV/EBITDA
29.9
35.7
27.7
25.8
37.3
27.4
EV/EBIT
36.9
43.8
33.9
31.9
47.7
34
EV/OCF
13
10.6
14.8
12.9
EV/FCF
13.4
17.6
11.9
17.5
Dividends
Statement data is not available for quarterly
Margins
Gross Profit Margin
43.3%
45.6%
46.7%
45.4%
45.9%
46.6%
Operating Margin
9.8%
12.2%
12.9%
13.5%
10.5%
14.3%
EBITDA Margin
12.6%
15.1%
15.8%
16%
13.4%
17.3%
Net Profit Margin
5.7%
7.7%
8.3%
7.5%
Effective Tax Rate
33.8%
27%
30%
16.3%
23.7%
20.5%
Pre-Tax Profit Margin
8.6%
11.9%
13.2%
Free Cash Flow Margin
35.1%
38.7%
12.8%
43.2%
25.9%
33.5%
OCF / Sales
39.9%
43%
17.4%
48.3%
30.1%
37.1%
OCF / Net Income
702.9%
557.7%
208.7%
457.6%
403%
354.4%
FCF / OCF
87.9%
90.2%
73.6%
89.6%
86.1%
FCF / Net Income
618.1%
502.9%
153.6%
409.9%
346.9%
319.8%
FCF / EBITDA
278.9%
256.8%
81.2%
269.4%
192.9%
193%
Capital Efficiency
Return on Invested Capital
3.2%
4.6%
4.9%
Return on Assets
1.6%
2.3%
3.3%
Return on Equity
11.2%
11.8%
17.2%
18%
Return on Total Capital
5.9%
8.4%
11.3%
7.4%
10.6%
Return on Capital Employed
7.1%
9%
9.3%
11%
7.9%
11.4%
Return on Tangible Assets
2%
2.1%
3%
Receivables Turnover
0.6
0.7
0.8
Days Sales Outstanding
586.4
571.7
570.3
502.3
512.6
462.1
Payables Turnover
1.2
1.1
Days Payables Outstanding
303.9
317.5
319.1
292.9
308.1
295.7
Inventory Turnover
10.7
12.4
10.1
11
Days Inventory Outstanding
37.1
34.1
33.5
29.4
36.1
33.2
Cash Conversion Cycle
319.6
288.3
284.6
238.8
240.6
199.6
Asset Turnover
0.2
0.3
Fixed Asset Turnover
2.3
2.5
2.4
2.6
Operating Cycle
623.5
605.8
603.8
531.7
548.7
495.3
CapEx to OCF
0.1
CapEx to Revenue
0
CapEx to Depreciation
1.7
1.4
1.6
2
Financial Health
Total Debt
9,877
8,979
7,726
6,850
6,324
5,403
Net Debt
-3,037
-2,543
-1,854
-2,334
-1,665
-2,493
Current Ratio
1.3
Quick Ratio
Cash Ratio
0.5
Debt Ratio
Assets to Equity
5.9
5.8
5.7
Cash Flow to Debt Ratio
0.4
Long-term Debt to Assets
Intangibles to Total Assets
Net Current Asset Value
-1,678
-1,173
-938
-703
-797
105
Goodwill / Assets
Debt / Equity
1.5
Total Debt / Capitalization
1
Long Term Debt / Capitalization
Long-Term Debt / Equity
0.9
Net Debt / EBITDA
-3.3
-2.5
-2
-2.4
-2.3
-2.8
EBIT / Interest Expense
20.7
22.9
19.6
17.1
13.9
18.6
EBITDA / Interest Expense
26.7
28.4
24
20.3
22.6
(EBITDA - Capex) / Interest Expense
16.5
20.5
17
12.3
Per Share
Revenue per Share
146.1
133.9
117.1
119.5
104.8
100.1
Basic EPS
8.3
10.3
9.7
7.8
10.5
Diluted EPS
Book Value per Share
122.6
112.7
98.7
85.8
78.9
72.1
Tangible Book Value per Share
117.2
107.4
93.8
81.7
75.1
68.2
Cash per Share
254.7
227.3
189
181.2
157.6
155.7
Operating Cash Flow per Share
58.4
57.5
57.7
31.6
Free Cash Flow per Share
51.3
51.9
51.7
27.2
CapEx per Share
7
6
3.6
Weighted Avg. Shares Outstanding
Weighted Avg. Shares Outstanding Diluted
Common Size
R&D to Revenue
8.5%
9.5%
9.1%
SG&A to Revenue
25.1%
24.5%
23.4%
23.2%
Stock-based Comp to Revenue
0.9%
0.8%
1.2%
